Berita/Reuters/Cytokinetics stops development of ALS drugCytokinetics stops development of ALS drug31 Mar 202311.39 UTCCYTKCytokinetics Inc CYTK said on Friday it had stopped a late-study stage of its treatment for amyotrophic lateral sclerosis (ALS), as the drug was found to be ineffective.